Diagnostics

News and analysis on diagnostic technologies and applications.

Roche Expands Global Access Program to Include Tuberculosis, Hepatitis, HPV Tests

The program started in 2014, originally to increase access to HIV diagnostics, and provides special pricing to qualifying organizations in eligible countries.

UPDATE: Cowen, William Blair, JP Morgan Initiate Coverage of Adaptive Biotechnologies

Cowen and William Blair initiated coverage of Adaptive with Outperform ratings, while JP Morgan assigned an Overweight rating and a $45 price target to the firm's stock.

Interpace Diagnostics, SelectHealth Sign Patient Coverage Agreement for Thyroid Cancer Tests

SelectHealth's physicians will be able to use Interpace's ThyGeNext and ThyraMir assays to test questionable thyroid nodules for thyroid cancer.

Myriad Genetics Settles Improper Medicare Billing Complaint for $9.1M

The company decided to settle the complaint in order to avoid "lengthy and distracting litigation," but denies any wrongdoing.

HiberGene Outlines Plans for Low-Cost Point-of-Care Molecular Diagnostic System

Premium

The Dublin, Ireland-based company plans to launch its new instrument by the end of 2021 and will pursue CLIA waiver in the US.

Jul 18, 2019

Theradiag Posts 9 Percent Increase in H1 2019 Revenues

Jul 18, 2019

Visceral Leishmaniasis Tests Lack Accuracy, Study Finds

Jul 18, 2019

Seer Raises $17.5 M in Series C Financing Round

Jul 18, 2019

CMS Meeting Suggests Growing Lab Interest in ADLT Status

Premium

Jul 18, 2019

Castle Bio Eyes up to $61.3M in Planned IPO

Jul 18, 2019

Startup Nephrosant Aims to Launch Noninvasive Kidney Transplantation Test by Early 2020

Premium

Jul 18, 2019

Life Sciences, Diagnostics Drive Danaher Q2 Revenues Up 4 Percent

Jul 18, 2019

Chembio Diagnostics, Shire Human Genetic Therapies Collaborate to Develop POC Biomarker Test

Jul 17, 2019

Parkinson's Foundation Project Seeks to ID Patient Disease Variants to Guide Therapy

Premium

Jul 17, 2019

Johns Hopkins Team Develops Test to Guide Pancreatic Cyst Treatment

Jul 17, 2019

Abbott Q2 Diagnostics Revenues Rise 2 Percent, MDx Revenues Down 12 Percent

Jul 16, 2019

Parkinson's Foundation, Fulgent Genetics Partner on Genetic Testing Initiative

Jul 16, 2019

Abbott Seeking Broader Adoption of Diabetes Testing With Point-of-Care Technology

Premium

Jul 16, 2019

Kephera Gets $594K NIH Grant for Determining Whether Chagas Patient Has Been Cured

Jul 16, 2019

Autoimmune Disease Diagnostic Firm Exagen Raises $22.6M

Jul 16, 2019

Qiagen Stock Downgraded to 'In Line' by Evercore ISI

Jul 16, 2019

Startup Cradle Genomics Raises $17.1M in Series A Round to Develop NIPT

Jul 16, 2019

IPS Genomix to Distribute Inivata's Tests in Middle East, Africa

Jul 16, 2019

Alnylam, 23andMe Partner on Free Family Testing Program for Hereditary ATTR Amyloidosis

Jul 16, 2019

Arcis Licenses Sample Prep Technology to microRNA Diagnostics Firm Mirnax Biosens

Featured White Papers

Delivering Precision Health: the Role of Molecular Diagnostics

Type 1 Interferon Gene Expression Analysis: Precision Medicine in Lupus

Jul

23

Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

30

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Jul

31

Featured Webinar

Considerations and Impact of Implementing Targeted NGS in Myeloid Malignancies

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.

Menu

Diagnostics

What's Popular?

Sponsorships